243 related articles for article (PubMed ID: 29717917)
1. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More.
Banoub M; Curless MS; Smith JM; Jarrell AS; Cosgrove SE; Rock C; Avdic E
Surg Infect (Larchmt); 2018 Jul; 19(5):504-509. PubMed ID: 29717917
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single-dose cefotetan and multidose cefoxitin as intravenous prophylaxis in elective, open biliary tract surgery: a multicentre, double-blind, randomized study.
Lapointe RW; Roy AF; Turgeon PL; Lewis RT; Dagenais MH; Joly JR; Scudamore CH; Roy PD; Conly JM; Syrotuik J
Can J Surg; 1994 Aug; 37(4):313-8. PubMed ID: 8055389
[TBL] [Abstract][Full Text] [Related]
3. Use and Effectiveness of Peri-Operative Cefotetan versus Cefazolin Plus Metronidazole for Prevention of Surgical Site Infection in Abdominal Surgery Patients.
Danan E; Smith J; Kruer RM; Avdic E; Lipsett P; Curless MS; Jarrell AS
Surg Infect (Larchmt); 2018; 19(4):388-396. PubMed ID: 29688837
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery.
Ho VP; Barie PS; Stein SL; Trencheva K; Milsom JW; Lee SW; Sonoda T
Surg Infect (Larchmt); 2011 Aug; 12(4):255-60. PubMed ID: 21790479
[TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.
Itani KM; Jensen EH; Finn TS; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2008 Apr; 9(2):131-7. PubMed ID: 18426345
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection.
Toma O; Suntrup P; Stefanescu A; London A; Mutch M; Kharasch E
Anesth Analg; 2011 Oct; 113(4):730-7. PubMed ID: 21642605
[TBL] [Abstract][Full Text] [Related]
7. Single-dose cefotetan or cefoxitin versus multiple-dose cefoxitin as prophylaxis in patients undergoing appendectomy for acute nonperforated appendicitis.
Liberman MA; Greason KL; Frame S; Ragland JJ
J Am Coll Surg; 1995 Jan; 180(1):77-80. PubMed ID: 8000659
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?
Hussain Z; Curtain C; Mirkazemi C; Gadd K; Peterson GM; Zaidi STR
Obes Surg; 2019 Jan; 29(1):159-165. PubMed ID: 30267229
[TBL] [Abstract][Full Text] [Related]
9. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.
Suffoletta TJ; Jennings HR; Oh JJ; Stephens D; Poe KL
Pharmacotherapy; 2008 Sep; 28(9):1133-9. PubMed ID: 18752384
[TBL] [Abstract][Full Text] [Related]
10. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery.
Jagelman DG; Fabian TC; Nichols RL; Stone HH; Wilson SE; Zellner SR
Am J Surg; 1988 May; 155(5A):71-6. PubMed ID: 3287972
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pre-operative cefazolin in obese patients.
Unger NR; Stein BJ
Surg Infect (Larchmt); 2014 Aug; 15(4):412-6. PubMed ID: 24824510
[TBL] [Abstract][Full Text] [Related]
12. Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter.
Deierhoi RJ; Dawes LG; Vick C; Itani KM; Hawn MT
J Am Coll Surg; 2013 Nov; 217(5):763-9. PubMed ID: 24045142
[TBL] [Abstract][Full Text] [Related]
13. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
Itani KM; Wilson SE; Awad SS; Jensen EH; Finn TS; Abramson MA
N Engl J Med; 2006 Dec; 355(25):2640-51. PubMed ID: 17182989
[TBL] [Abstract][Full Text] [Related]
14. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
Blum S; Cunha CB; Cunha BA
Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
[TBL] [Abstract][Full Text] [Related]
15. Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study.
Periti P; Mazzei T; Tonelli F
Dis Colon Rectum; 1989 Feb; 32(2):121-7. PubMed ID: 2644108
[TBL] [Abstract][Full Text] [Related]
16. Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More.
Sommerstein R; Atkinson A; Kuster SP; Vuichard-Gysin D; Harbarth S; Troillet N; Widmer AF;
JAMA Netw Open; 2021 Dec; 4(12):e2138926. PubMed ID: 34910149
[TBL] [Abstract][Full Text] [Related]
17. Multicenter open trial of cefotetan and cefoxitin in elective biliary surgery.
Fabian TC; Zellner SR; Gazzaniga A; Hanna C; Nichols RL; Waxman K
Am J Surg; 1988 May; 155(5A):77-80. PubMed ID: 3287973
[TBL] [Abstract][Full Text] [Related]
18. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients.
Peppard WJ; Eberle DG; Kugler NW; Mabrey DM; Weigelt JA
Surg Infect (Larchmt); 2017; 18(4):485-490. PubMed ID: 27906601
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy.
Berkeley AS; Freedman KS; Ledger WJ; Orr JW; Benigno BB; Gordon SF; McGregor JA; Galask RP; Sevin BU
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):706-9. PubMed ID: 3128112
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy.
Berkeley AS; Orr JW; Cavanagh D; Freedman KS; Ledger WJ; Pastorek JG; Sevin BU
Am J Surg; 1988 May; 155(5A):81-5. PubMed ID: 3287974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
